VEGFA and ischemia: Mechanistically, CCT reduction after anti-VEGF may reflect decreased choroidal permeability, vascular regression, and remodeling [28,29], which could exacerbate ischemia or structural compromise; VEGF-dependency may therefore persist and durability remain limited despite potent suppression [29–31].